Fermentation analogs of virginiamycin M1
AssigneeMerck & Co., Inc.
InventorsYiu-Kuen T. Lam, Raymond S. Chang, Otto D. Hensens, Cheryl D. Schwartz, Deborah L. Zink
Life of this patent
Estimating the term…
Loading patent…
AssigneeMerck & Co., Inc.
InventorsYiu-Kuen T. Lam, Raymond S. Chang, Otto D. Hensens, Cheryl D. Schwartz, Deborah L. Zink
Estimating the term…
Virginiamycin M.sub.1 having the Formula: ##STR1## and virginiamycin M.sub.1 analogs having the Formulae I-IV: ##STR2## Virginiamycin M.sub.1 and the analogs I-IV are antagonists of cholecystokinin (CCK) and gastrin. Cholecystokinin antagonists are useful as analgesics and in the treatment and prevention of disorders of the gastrointestinal, central nervous and appetite regulatory systems in animals, especially humans. Gastrin antagonists are useful in blocking the receptors for gastrin in humans and may function as agents for the treatment of ulcers, tumors or other gastrointestinal disorders. The compounds of Formulae I-IV are also antibiotics and are useful as antimicrobial agents in animals including man and are useful as food additives to promote feed utilization in animals. Virginiamycin M.sub.1 and the analogs of Formula I, III, and IV are produced by the controlled aerobic fermentation of a strain of Streptomyces olivaceus, ATCC No. 53527, while the analog of Formula II is produced by chemical synthesis.
A compound of the Formula I:
A compound of the Formula III:
A compound of the Formula IV:
A mixture of virginiamycin M.sub.1 and the compounds of Formulae I, III, and IV produced by the fermentation of a strain of Streptomyces olivaceus in an assimilable nutrient medium.
A method of purifying virginiamycin M.sub.1 and the compounds of Formulae I, III, and IV comprising the following steps:
Dependencies are inferred from the claim text.